(-0.05%) 5 329.00 points
(-0.03%) 39 932 points
(-0.18%) 18 730 points
(-1.98%) $78.22
(-2.07%) $2.69
(-0.27%) $2 432.00
(-1.21%) $32.04
(-0.12%) $1 062.40
(0.05%) $0.921
(-0.23%) $10.67
(-0.02%) $0.787
(-0.16%) $90.54
Live Chart Being Loaded With Signals
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder...
Stats | |
---|---|
Šios dienos apimtis | 2 250.00 |
Vidutinė apimtis | 4 520.00 |
Rinkos kapitalizacija | 65.85M |
EPS | $0 ( 2024-01-26 ) |
Last Dividend | $0.220 ( 2018-02-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | -11.24 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2018-02-28 | Anschutz Philip F | Sell | 12 440 000 | CLASS A COMMON STOCK |
2018-02-28 | Anschutz Philip F | Sell | 23 708 639 | CLASS B COMMON STOCK |
2018-02-28 | Campbell Michael L | Sell | 703 660 | Class A Common Stock |
2018-02-28 | Yemenidjian Alex | Sell | 21 880 | Class A Common Stock |
2018-02-28 | Tyrrell Jack | Sell | 136 684 | Class A Common Stock |
INSIDER POWER |
---|
0.00 |
Last 97 transactions |
Buy: 583 544 | Sell: 71 137 085 |
Regencell Bioscience Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
QNRX | 0.939 |
RGF | 0.934 |
TCPC | 0.932 |
ACAD | 0.928 |
BNRG | 0.926 |
AGRX | 0.924 |
CNXC | 0.922 |
BCAN | 0.922 |
RRGB | 0.919 |
IRDM | 0.916 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
ROAD | -0.958 |
PVAL | -0.947 |
EQRR | -0.944 |
IUS | -0.941 |
DVLU | -0.939 |
RNA | -0.937 |
MNMD | -0.936 |
CPRT | -0.935 |
ALLT | -0.935 |
AIRG | -0.934 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Regencell Bioscience Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $0 |
Bruto pelnas: | $-769 687 (0.00 %) |
EPS: | $-0.450 |
FY | 2023 |
Pajamos: | $0 |
Bruto pelnas: | $-769 687 (0.00 %) |
EPS: | $-0.450 |
FY | 2022 |
Pajamos: | $0 |
Bruto pelnas: | $-604 397 (0.00 %) |
EPS: | $-0.570 |
FY | 2021 |
Pajamos: | $0.00 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-0.107 |
Financial Reports:
No articles found.
Regencell Bioscience Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.180 | 2009-06-02 |
Last Dividend | $0.220 | 2018-02-15 |
Next Dividend | $0 | N/A |
Payout Date | 2018-02-26 | |
Next Payout Date | N/A | |
# dividends | 36 | -- |
Total Paid Out | $7.52 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.86 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
Unable to generate commentary due to missing data.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
OXLC | Dividend Diamond | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend Royal | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0 | 1.500 | 0 | 0 | [0 - 0.5] |
returnOnAssetsTTM | -0.465 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.455 | 1.500 | -6.17 | -9.25 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 19.15 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 19.15 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.58 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0367 | -1.500 | 9.39 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.118 | 2.00 | 9.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.118 | 2.00 | 9.94 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0385 | -1.500 | 9.85 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0 | 1.000 | -3.33 | -3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0 | 1.000 | -2.00 | -2.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.32 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.66 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -11.21 | 1.000 | -1.234 | 0 | [1 - 100] |
returnOnEquityTTM | -0.455 | 2.50 | -3.96 | -9.25 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.118 | 2.00 | 9.96 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.118 | 2.00 | 9.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.254 | 1.500 | -5.03 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | -0.119 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Regencell Bioscience
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.